Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2026)

Teladoc Health (TDOC) has 8 years of Current Deferred Revenue data on file, last reported at $65.7 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue fell 21.94% year-over-year to $65.7 million; the trailing twelve-month figure through Mar 2026 stood at $65.7 million (down 21.94% YoY), and the FY2025 full-year result was $71.4 million, down 19.8% from the prior year.
• Current Deferred Revenue retreated to $65.7 million in Q1 2026, from $71.4 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $121.6 million in Q2 2023 to a low of $65.7 million in Q1 2026.
• A 5-year average of $98.4 million and a median of $107.2 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue soared 50.57% in 2022 and retreated 29.0% in 2025, its largest moves.
• Tracing TDOC's Current Deferred Revenue over 5 years: stood at $113.8 million in 2022, then dropped by 3.96% to $109.3 million in 2023, then dropped by 18.48% to $89.1 million in 2024, then slipped by 19.8% to $71.4 million in 2025, then fell by 8.02% to $65.7 million in 2026.
• Business Quant data shows TDOC's Current Deferred Revenue at $65.7 million in Q1 2026, $71.4 million in Q4 2025, and $70.1 million in Q3 2025.